🇺🇸 FDA
Patent

US 8497357

Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom

granted A61KA61K47/60

Quick answer

US patent 8497357 (Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom) held by Nektar Therapeutics expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K47/60